The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey

The dogma of Cetuximab and Radiotherapy in head and neck cancer – A dawn to dusk journey

Since the introduction of Cetuximab as a biological molecule against Epidermal Growth Factor Receptor (EGFR), its use in the cancers of head and neck region is widely explored. With the recognition that EGFR expression is associated with radioresistance and poor prognosis, incorporation of an anti-E...

Full description

Bibliographic Details
Main Authors: Sapna Krishnamurthy, Imtiaz Ahmed, Rohan Bhise, Bidhu K Mohanti, Atul Sharma, Thorsten Rieckmann, Claire Paterson, Pierluigi Bonomo
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Head and neck cancer
Cetuximab
Bio-radiotherapy
Chemoradiation
anti- EGFR
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630822000222

Internet

http://www.sciencedirect.com/science/article/pii/S2405630822000222

Similar Items